로그인 회원가입
icon_bulk_order대량 주문 조회 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > IL-3 R alpha

IL-3 R alpha

요약

Name:Interleukin-3 receptor subunit alpha
Target Synonym:IL3RY,IL-3RA,CD123 Antigen,IL3RX,IL-3R Subunit Alpha,IL3R,IL-3 Receptor Subunit Alpha,IL-3 Receptor Alpha SP2 Isoform,Interleukin 3 Receptor Subunit Alpha,IL3RAY,IL-3R-Alpha,CD123,HIL-3Ra,IL3RA,Interleukin 3 Receptor, Alpha (Low Affinity),Interleukin-3 Receptor Subunit Alpha,Interleukin-3 Receptor alpha Subunit
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:22
Lastest Research Phase:Approved

제품 리스트 비교 또는 구매

일부의 생물활성 데이터

ILA-HP2H8-Cell-based assay
FACS assay shows that recombinant Biotinylated FACS

5e5 of anti-IL-3 R alpha CAR-293 cells were stained with 100 μL of 1:25 dilution (4 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human IL-3 R alpha, His Tag (Cat. No. ILA-HP2H8) and negative control protein respectively. PE signal was used to evaluate the binding activity (QC tested).

ILA-HF253-Cell-based assay
FACS assay shows that recombinant Biotinylated FACS

2e5 of anti-IL-3 R alpha CAR-293 cells were stained with 100 μL of 10 μg/mL of FITC-Labeled Human IL-3 R alpha, Fc Tag (Cat. No. ILA-HF253) and negative control protein respectively and analyzed with FACS (QC tested).

ILA-H5252-SPR
Human_FcRn_Heterodimer_Protein_SPR

Anti-IL-3 R alpha Antibody, Human IgG1 immobilized on CM5 Chip can bind Human IL-3 R alpha, Fc Tag (Cat. No. ILA-H5252) with an affinity constant of 50.3 nM as determined in a SPR assay (Biacore T200) (QC tested).

ILA-M52H4-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Mouse IL-3 R alpha, His Tag (Cat. No. ILA-M52H4) on CM5 Chip can bind Mouse IL-3 Protein, His Tag (Cat. No. IL3-M52H8) with an affinity constant of 0.929 μM as determined in a SPR assay (Biacore T200) (QC tested).

사용자 리뷰

Synonym Name

IL3R,IL3RA,IL-3Ra,IL-3R-alpha,IL3RAY,IL3RX,IL3RY,CD123 antigen,CD123,hIL3Ra,hIL-3Ra,MGC34174,IL-3 R alpha

Background

Interleukin 3 receptor alpha (low affinity) (IL3RA), also known as CD123 (Cluster of Differentiation 123) is a 70-kD glycoprotein member of the hematopoietin receptor superfamily. This protein associates with a beta subunit common to the receptors for IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) to form a high-affinity receptor for IL-3. The interleukin-3 receptor α chain (CD123) has been identified as a potential immunotherapeutic target because it is overexpressed in AML compared with normal hematopoietic stem cells.

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Tagraxofusp DTIL-3; DT388 IL3; SL-401 Approved Texas A&M University Development Foundation Elzonris EU Lymphoma; Blastic Plasmacytoid Dendritic Cell Neoplasm Stemline Therapeutics Inc, Stemline Therapeutics 2018-12-21 Leukemia, Myelomonocytic, Chronic; Blastic Plasmacytoid Dendritic Cell Neoplasm; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Lymphoma Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Anti-CD123 CAR T-cell therapy (Southwest Hospital) Phase 2 Clinical Southwest Hospital Chongqing Leukemia, Myeloid Details
Anti-CD123 CAR T-cell therapy (Nanjing Legend Biotech) Phase 1 Clinical Nanjing Legend Biotechnology Co Ltd Leukemia, Myeloid, Acute Details
Anti-CD123 CAR T cell therapy (Shanghai GeneChem) Phase 1 Clinical Shanghai Genechem Co Ltd Leukemia, Myeloid, Acute Details
SQZ-622(Novartis Pharma) SQZ-622 Phase 1 Clinical Novartis Pharma Ag Leukemia, Myeloid, Acute Details
Anti-CD123 CAR T-cell therapy (University of Pennsylvania/Novartis) JEZ-567 Phase 1 Clinical Novartis Pharma Ag, University Of Pennsylvania Leukemia, Myeloid, Acute Details
UniCAR02-T UniCAR02-T Phase 1 Clinical Cellex Patient Treatment Gmbh Kidney Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
KHK-2823 KHK-2823 Kyowa Hakko Kirin Details
CD123 CAR-T cells (Hebei Senlang Biotechnology) Hebei Senlang Biological Technology Co Ltd Details
Anti-CD123 CAR-T cell therapy (Wuhan Union Hospital) Wuhan Union Hospital Details
CD123 CAR-T cell therapy(Chongqing Precision Biotechnology) Chongqing Precision Biotechnology Co Ltd Details
CD123/CLL1 CAR-T Cell Therapy (Fujian Medical University) Fujian Medical University Details
IM-23 (Beijing Immunochina Medical Science and Technology) IM-23; IM-23 CAR-T Beijing Immunochina Medical Science & Technology Co Ltd Details
JNJ-63709178 JNJ-9178; CNTO-9958; JNJ-63709178 Janssen Global Services Llc, Genmab Details
SGN-CD123A SGN-CD123A Seattle Genetics Inc Details
Pivekimab sunirine IMGN-632 Immunogen Details
UCART-123 UCART-123 Cellectis Details
CSL-360 IL-3Rα; CSL-360 Csl Ltd Details
Flotetuzumab S-80880; MGD-006; RES-234 Macrogenics Details
ACLX-002 ACLX-002 Phase 1 Clinical Arcellx Myelodysplastic Syndromes; Leukemia, Myeloid, Acute Details
APVO436 APVO-436 Phase 1 Clinical Aptevo Myeloproliferative Disorders; Leukemia, Myeloid, Acute Details
UniCAR-T-CD-123 UniCAR-T-CD123 Phase 1 Clinical Gemoab Monoclonals Gmbh Leukemia, Myeloid, Acute Details
Vibecotamab XmAb-14045 Phase 1 Clinical Xencor Leukemia, Myeloid; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute Details
Talacotuzumab CSL-362; JNJ-473; CSL-362-AML; JNJ-56022473; IL-13 MAb-CSL Phase 2 Clinical Csl Ltd Myelodysplastic Syndromes; Leukemia, Myeloid, Acute Details
MB-102 (Mustang Bio) MB-102 Phase 3 Clinical Mustang Bio, City Of Hope National Medical Center Neoplasm, Residual; Acute Kidney Injury; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Biphenotypic, Acute Details

This web search service is supported by Google Inc.

totop